Delivery Order SPE2DB20D3103-SPE2DB22FP2M2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,541.09, is for the delivery of 4,563,004,539 units of the anti-infective medication Cefixime 400 mg capsules. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.47, is for the delivery of 4560878924 Cefixime 400 mg capsules. The award is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- The Defense Logistics Agency awarded a $2,312.76 delivery order to AmerisourceBergen Drug Corp for Cefixime 400 mg capsules (50 count) on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The award will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,456.32 to AmerisourceBergen Drug Corp for the supply of Cefixime 400 mg capsules (50-count units). This contract, issued on December 9, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 10, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,530.68 firm fixed-price delivery order is for the supply of 4,567,859,134 units of the pharmaceutical product CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,732.22 for Cefixime 400 mg capsules (50-count units) with an ultimate completion date of December 8, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The company will perform the delivery from its corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed-price delivery order is for the supply of 4566947370 CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,359.28 firm-fixed-price delivery order is for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS medical products, with a period of performance through November 16, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,129.14 firm fixed-price delivery order is for the supply of 4565165651 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,819.12 firm fixed-price delivery order is for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract has a completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP2M2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,727.23 firm fixed-price delivery order is for the supply of Cefixime 400 mg capsules, with a completion date of July 20, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 7/19/22 |